| 9 | pimonidazoleIBA
03/2014
-
06/2005 |
| 6 | Proteins (Proteins, Gene)FDA Link
01/2020
-
08/2007 |
| 5 | bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
03/2014
-
06/2005 |
| 3 | LigandsIBA
01/2018
-
01/2017 |
| 3 | fluoromisonidazoleIBA
03/2014
-
03/2009 |
| 3 | Biomarkers (Surrogate Marker)IBA
11/2013
-
03/2011 |
| 3 | sodium-iodide symporter (sodium iodide symporter)IBA
12/2012
-
10/2002 |
| 3 | Carbonic Anhydrase IXIBA
05/2010
-
08/2007 |
| 3 | Oxygen (Dioxygen)IBA
07/2009
-
08/2008 |
| 2 | 3-Iodobenzylguanidine (Iobenguane)IBA
01/2022
-
08/2003 |
| 2 | Radioisotopes (Radionuclides)IBA
01/2019
-
01/2018 |
| 2 | Monoclonal AntibodiesIBA
11/2013
-
04/2006 |
| 2 | IodineIBA
07/2009
-
08/2008 |
| 2 | carbogenIBA
03/2009
-
08/2007 |
| 2 | Bromodeoxyuridine (BrdU)IBA
08/2007
-
06/2005 |
| 1 | RadiopharmaceuticalsIBA
01/2022 |
| 1 | meta-((211)At)astatobenzylguanidineIBA
01/2022 |
| 1 | Silicon Dioxide (Silica)FDA LinkGeneric
01/2020 |
| 1 | IntegrinsIBA
01/2020 |
| 1 | Peptides (Polypeptides)IBA
01/2020 |
| 1 | Glucose (Dextrose)FDA LinkGeneric
10/2019 |
| 1 | Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA
10/2019 |
| 1 | LipopolysaccharidesIBA
10/2019 |
| 1 | TurpentineIBA
10/2019 |
| 1 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 |
| 1 | SolutionsIBA
05/2018 |
| 1 | AcidsIBA
05/2018 |
| 1 | Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2018 |
| 1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2018 |
| 1 | Neurokinin-1 Receptor AntagonistsIBA
01/2018 |
| 1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2017 |
| 1 | Gastrin-Releasing PeptideIBA
01/2017 |
| 1 | GalliumIBA
01/2017 |
| 1 | piperidineIBA
01/2017 |
| 1 | Bombesin Receptors (Bombesin Receptor)IBA
01/2017 |
| 1 | procaine isothiocyanate (PRIT)IBA
01/2017 |
| 1 | DNA (Deoxyribonucleic Acid)IBA
05/2016 |
| 1 | ParaffinIBA
05/2016 |
| 1 | Hormones (Hormone)IBA
05/2016 |
| 1 | Formaldehyde (Formol)FDA Link
05/2016 |
| 1 | AntigensIBA
10/2015 |
| 1 | Immunoconjugates (Immunoconjugate)IBA
10/2015 |
| 1 | Diacetyl (Biacetyl)IBA
03/2014 |
| 1 | NitroimidazolesIBA
03/2014 |
| 1 | fluoroazomycin arabinosideIBA
03/2014 |
| 1 | copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
03/2014 |
| 1 | GadoliniumIBA
02/2013 |
| 1 | cediranib (AZD2171)IBA
02/2013 |
| 1 | Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link
12/2012 |
| 1 | Dihydrotachysterol (AT 10)IBA
01/2012 |
| 1 | Green Fluorescent ProteinsIBA
01/2012 |
| 1 | Serum AlbuminIBA
04/2011 |
| 1 | vadimezanIBA
03/2011 |
| 1 | Immunoglobulin G (IgG)IBA
05/2010 |
| 1 | 1- (6- deoxy- 6- iodogalactopyranosyl)- 2- nitroimidazoleIBA
07/2009 |
| 1 | A-factor (Streptomyces)IBA
07/2009 |
| 1 | Gadolinium DTPA (Magnevist)FDA Link
03/2009 |
| 1 | Hematoxylin (Haematoxylon)IBA
03/2009 |
| 1 | Eosine Yellowish-(YS) (Eosin)IBA
03/2009 |
| 1 | benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
01/2009 |
| 1 | Galactose (Galactopyranose)FDA LinkGeneric
08/2008 |
| 1 | Trastuzumab (Herceptin)FDA Link
04/2006 |
| 1 | Cytotoxins (Cytolysins)IBA
04/2006 |
| 1 | Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
08/2003 |
| 1 | Complementary DNA (cDNA)IBA
08/2003 |
| 1 | N-acetyltalosaminuronic acid (NAT)IBA
08/2003 |
| 1 | Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA
08/2003 |
| 1 | Messenger RNA (mRNA)IBA
08/2003 |
